Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

FDA to review AmBisome NDA

Jan. 14, 1997

More oxazolidinone antimicrobial agents under study at P&U

Jan. 14, 1997

Merck & Co. discloses novel antifungal agents

Jan. 14, 1997

The Liposome Company's Abelcet receives marketing approval in 14th country

Jan. 13, 1997

Sequus' Amphotec earns 19th marketing approval

Jan. 10, 1997

Merck & Co. describes avermectin analogue

Jan. 10, 1997

Gilead files NDA for new cidofovir formulation

Jan. 7, 1997

Fujisawa reveals antibacterial series

Jan. 7, 1997

Kaken describes novel antibacterial agents

Jan. 7, 1997

Yale receives grant from Vion

Jan. 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...